some default text...
Select Committee on International Development Minutes of Evidence


Attachment

CONTINUUM OF CARE


Voluntary, Confidential Counselling and testing—
including lab
facilities
Psycho-
social
support
Diet and
nutrition
Local remedies for
Ols
Basic Ol
treatment and
prophylaxis-with lab
and monitoring services
e.g. TB
Mother-to-child transmission prevention—with pre-and
post-natal services
Palliative care
Complex Ol
treatments (antibiotics and anti
fungals e.g
fluconazole)
Anti retroviral
treatment
with lab,
monitoring and clinical
expertise

Medium
Cheap
Cheap
Cheap
Medium
Medium-
Expensive
Medium
Medium-
Expensive
Expensive

Community capacity building— eg treatment advocates, self-help groups, community-based care programmes

Build local health infrasructure

Increase community awareness and treatment literacy eg importance of adherence

Notes:

  1.  Current discussions regarding the price of a range of ARVs and OI treatment of drugs (eg fluconazole) make it difficult to attach figures to the cost of drug provision. The indicative cost bands above suggest price ranges that include product cost and implementation costs.

  2.  Building health infra-structure and community capacity are critical elements in developing a care continuum. Governments, international donors and local communities all have key roles and responsibilities in this development. Private sector and employer provision may also be important in broadening access to care.

  3.  For estimates of cost of drug treatment see:

Foreman, M (2000), Beyond our Means? The Cost of Treating HIV/AIDS in the Developing World. Panos: London Gilks et al (1998), Care and Support for People with HIV/AIDS in Resource-Poor Settings. DFID: London.


 
previous page contents next page

House of Commons home page Parliament home page House of Lords home page search page enquiries index

© Parliamentary copyright 2001
Prepared 29 March 2001